Anthropic IPO filing flags healthcare, drug discovery as growth bets
Anthropic filed its S-1 registration statement with the SEC on Oct. 26, naming healthcare and life sciences among the new markets the Claude developer intends to enter as it prepares to list on the Nasdaq Global Select Market under the ticker “ANT.” The filing frames drug discovery as a leading use case. Customers, biotechnology partners […] The post Anthropic IPO filing flags healthcare, drug discovery as growth bets appeared first on Becker's Hospital Review | Healthcare News &...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.